The body's calcium guard — released by four rice-grain glands whenever blood calcium dips, PTH pulls calcium from bone, reclaims it from urine, and activates vitamin D to absorb it from food. Ionized calcium is held in a band so narrow that PTH moves three organs at once to defend it.
Chemical Class
Peptide (84 aa, N-terminal 1–34 is the active fragment)
Minute-to-minute control by the CaSR: falling ionized calcium releases PTH within seconds; rising calcium silences it — the fastest feedback loop among the peptide hormones.
Magnesium modulates (severe hypomagnesemia paradoxically paralyzes PTH release — hypocalcemia that won't correct until magnesium does).
Phosphate retention (CKD) raises PTH chronically by lowering calcium and calcitriol; fibroblast growth factor 23 adds its own suppression (FGF23-klotho axis).
Vitamin D (calcitriol) feeds back directly on parathyroid gene expression — the basis of treating secondary hyperparathyroidism with active vitamin D.
Mechanism of Action
PTH1R sits on osteoblasts, not osteoclasts — PTH borrows the bone-remodeling coupling: osteoblasts respond by raising RANKL, which recruits and activates osteoclasts to resorb bone (RANK/RANKL remodeling). In the kidney, PTH makes distal tubules reclaim filtered calcium while proximal tubules excrete phosphate (phosphaturic). It also switches on kidney 1α-hydroxylase, producing calcitriol — gut absorption follows (calcium-phosphate axis).
Physiological Effects
Bone: intermittent PTH builds bone (the osteoanabolic paradox behind teriparatide therapy); continuous PTH destroys it — timing flips the effect.
Gut: indirect calcium and phosphate absorption up via calcitriol within days.
Net: serum calcium rises, phosphate falls — the signature that separates PTH excess from vitamin D excess (both calcium high, phosphate differs).
Interactions & Feedback
Antagonist: calcitonin brackets calcium from the high side; PTH from the low side.
Teammate: calcitriol — PTH manufactures its partner by activating the vitamin D endgame (vitamin D metabolism).
Estrogen loss at menopause unleashes cytokine-driven resorption that PTH's set-point drifts to accommodate — postmenopausal osteoporosis.
When It Goes Wrong
Primary hyperparathyroidism (usually a single adenoma): hypercalcemia with inappropriately normal-or-high PTH — "stones, bones, abdominal groans, psychiatric overtones".
Secondary hyperparathyroidism of CKD: sustained low calcitriol and high phosphate drive PTH ever upward — renal osteodystrophy.
Hypoparathyroidism (surgery, autoimmune, DiGeorge): hypocalcemia with neuromuscular irritability — Chvostek and Trousseau signs, tetany; treated with calcitriol and calcium (PTH analogs now exist).
Pseudohypoparathyroidism: hormone resistance — high PTH with low calcium (the target's fault, not the gland's).